Icon price target lowered to $255 from $270 at BofA
BofA analyst Michael Ryskin lowered the firm’s price target on Icon (ICLR) to $255 from $270 and keeps a Buy rating on the shares. The firm ...
Business Insider16d
Icon sees FY25 adjusted EPS $13.00-$15.00, consensus $14.93
Sees FY25 revenue $8.05B-$8.65B, consensus $8.5B. CEO Steve Cutler commented, “ICON (ICLR) continues to navigate dynamic clinical development market conditions, as trial activity has been ...